1. Ackenheil M, Albus M, Bondy B, Müller-Spahn F, Münch U, Naber D (1985) Biochemical and neuroendocrine studies in schizophrenia: attempts to characterize the illness biochemically. In: Beckmann H, Riederer P (eds) Pathochemical markers in major psychosis. Springer, Berlin Heidelberg New York Tokyo, pp 78–87
2. Angrist B, van Kammen DP (1984) CNS stimulants as tools in the study of schizophrenia. TINS 7:388–390
3. Bischoff S, Delini-Stula A, Maitre L (1985) Blockade der Dopamin-Rezeptoren im Hippokam-pus als Indikator antipsychotischer Wirksamkeit: Korrelationen zwischen Neuroleptika. In: Pflug B, Foerster K, Straube E (Hrsg) Perspektiven der Schizophrenie-Forschung. Fischer, Stuttgart, S 87–103
4. Bürki HR (1986) Effects of fluperlapin on dopaminergic systems in rat brain. Psychopharmacology 89:77–84
5. Carlsson A (1978) Does dopamine have a role in schizophrenia? Biological Psychiatry 13:3–21